248 related articles for article (PubMed ID: 18699939)
1. Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily.
Rozsasi A; Polzehl D; Deutschle T; Smith E; Wiesmiller K; Riechelmann H; Keck T
Allergy; 2008 Sep; 63(9):1228-34. PubMed ID: 18699939
[TBL] [Abstract][Full Text] [Related]
2. [Aspirin sensitivity: long term follow-up after up to 3 years of adaptive desensitization using a maintenance dose of 100 mg of aspirin a day].
Gosepath J; Schäfer D; Mann WJ
Laryngorhinootologie; 2002 Oct; 81(10):732-8. PubMed ID: 12397524
[TBL] [Abstract][Full Text] [Related]
3. [Self-desensitization with aspirin in a patient with aspirin intolerance].
Rozsasi A; Keck T
Laryngorhinootologie; 2009 Aug; 88(8):540-1. PubMed ID: 19562656
[No Abstract] [Full Text] [Related]
4. Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study.
Świerczyńska-Krępa M; Sanak M; Bochenek G; Stręk P; Ćmiel A; Gielicz A; Plutecka H; Szczeklik A; Niżankowska-Mogilnicka E
J Allergy Clin Immunol; 2014 Oct; 134(4):883-90. PubMed ID: 24767875
[TBL] [Abstract][Full Text] [Related]
5. Long-term Clinical Outcomes of Aspirin Desensitization With Continuous Daily Aspirin Therapy in Aspirin-exacerbated Respiratory Disease.
Walters KM; Waldram JD; Woessner KM; White AA
Am J Rhinol Allergy; 2018 Jul; 32(4):280-286. PubMed ID: 29682983
[TBL] [Abstract][Full Text] [Related]
6. Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease.
Cho KS; Soudry E; Psaltis AJ; Nadeau KC; McGhee SA; Nayak JV; Hwang PH
Otolaryngol Head Neck Surg; 2014 Oct; 151(4):575-81. PubMed ID: 25118195
[TBL] [Abstract][Full Text] [Related]
7. Phenomenology, pathogenesis, diagnosis and treatment of aspirin-sensitive rhinosinusitis.
Schapowal AG; Simon HU; Schmitz-Schumann M
Acta Otorhinolaryngol Belg; 1995; 49(3):235-50. PubMed ID: 7484142
[TBL] [Abstract][Full Text] [Related]
8. Eicosanoids, aspirin-intolerance and the upper airways--current standards and recent improvements of the desensitization therapy.
Pfaar O; Klimek L
J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():5-13. PubMed ID: 17244950
[TBL] [Abstract][Full Text] [Related]
9. Low-dose aspirin desensitization in individuals with aspirin-exacerbated respiratory disease.
Fruth K; Pogorzelski B; Schmidtmann I; Springer J; Fennan N; Fraessdorf N; Boessert A; Schaefer D; Gosepath J; Mann WJ
Allergy; 2013; 68(5):659-65. PubMed ID: 23464577
[TBL] [Abstract][Full Text] [Related]
10. [Long-term efficacy of aspirin desensitization in aspirin-exacerbated respiratory disease. Review of two clinical cases].
Cambray-Gutiérrez JC; García-Ramírez UN; Del Rivero-Hernández LG; Lozano-Martínez SA; López-Pérez P; Chávez-García A
Rev Alerg Mex; 2016; 63(2):207-12. PubMed ID: 27174764
[TBL] [Abstract][Full Text] [Related]
11. The role of aspirin desensitization in patients with aspirin-exacerbated respiratory disease (AERD).
Spies JW; Valera FC; Cordeiro DL; de Mendonça TN; Leite MG; Tamashiro E; Arruda LK; Anselmo-Lima WT
Braz J Otorhinolaryngol; 2016; 82(3):263-8. PubMed ID: 26601997
[TBL] [Abstract][Full Text] [Related]
12. Aspirin desensitization for ASA triad patients--prospective study of the rhinologist`s perspective.
Forer B; Kivity S; Sade J; Landsberg R
Rhinology; 2011 Mar; 49(1):95-9. PubMed ID: 21468382
[TBL] [Abstract][Full Text] [Related]
13. Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease.
Lee JY; Simon RA; Stevenson DD
J Allergy Clin Immunol; 2007 Jan; 119(1):157-64. PubMed ID: 17208597
[TBL] [Abstract][Full Text] [Related]
14. Intranasal lysine-aspirin administration decreases polyp volume in patients with aspirin-intolerant asthma.
Ogata N; Darby Y; Scadding G
J Laryngol Otol; 2007 Dec; 121(12):1156-60. PubMed ID: 17697437
[TBL] [Abstract][Full Text] [Related]
15. Aspirin desensitization for patients with aspirin-exacerbated respiratory disease: A randomized double-blind placebo-controlled trial.
Esmaeilzadeh H; Nabavi M; Aryan Z; Arshi S; Bemanian MH; Fallahpour M; Mortazavi N
Clin Immunol; 2015 Oct; 160(2):349-57. PubMed ID: 26083948
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of aspirin hypersensitivity in patients with nasal polyposis and contributing factors.
Bavbek S; Dursun B; Dursun E; Korkmaz H; Sertkaya Karasoy D
Am J Rhinol Allergy; 2011; 25(6):411-5. PubMed ID: 22185746
[TBL] [Abstract][Full Text] [Related]
17. Intranasal lysine-aspirin in aspirin-sensitive nasal polyposis: a controlled trial.
Parikh AA; Scadding GK
Laryngoscope; 2005 Aug; 115(8):1385-90. PubMed ID: 16094110
[TBL] [Abstract][Full Text] [Related]
18. Does it make sense to "desens"? Aspirin desensitization in the treatment of chronic rhinosinusitis.
Lee JY; Simon RA
Curr Allergy Asthma Rep; 2006 May; 6(3):183-4. PubMed ID: 16579867
[No Abstract] [Full Text] [Related]
19. An Hourly Dose-Escalation Desensitization Protocol for Aspirin-Exacerbated Respiratory Disease.
Chen JR; Buchmiller BL; Khan DA
J Allergy Clin Immunol Pract; 2015; 3(6):926-31.e1. PubMed ID: 26282158
[TBL] [Abstract][Full Text] [Related]
20. [Melatonin expression in nasal polyps in patients with asthmatic triad].
Evsiukova EV; Okuneva EIu; Zubzhitskaia LB; Kvetnoĭ IM
Arkh Patol; 2008; 70(3):33-5. PubMed ID: 18727430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
